|
|
40
|
4331AB
|
SUTENT 12.5MG TAB (PFI/STO) SUNITINIB
|
28'S
|
C
|
123.35
|
12.5MG
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
|
41
|
4331AB
|
SUTENT 12.5MG TAB (PFI) SUNITINIB (BQ)
|
28'S
|
BQ
|
123.3527
|
12.5MG
|
0
|
2024-04-01
|
2026-03-31
|
|
|
|
6
|
|
|
42
|
4331AB
|
SUTENT 12.5MG CAP (PFI) SUNITINIB
|
28'S
|
C
|
123.35
|
12.5MG
|
0
|
2026-04-01
|
|
No
|
No
|
|
6
|
|
|
40
|
4331AC
|
SUTENT 25MG TAB (PFI/STO) SUNITINIB
|
28'S
|
C
|
242.59
|
25MG
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
|
41
|
4331AC
|
SUTENT 25MG TAB (PFI) SUNITINIB (BQ)
|
28'S
|
BQ
|
242.5929
|
25MG
|
0
|
2024-04-01
|
2026-03-31
|
|
|
|
6
|
|
|
42
|
4331AC
|
SUTENT 25MG CAP (PFI) SUNITINIB
|
28'S
|
C
|
242.59
|
25MG
|
0
|
2026-04-01
|
|
No
|
No
|
|
6
|
|
|
42
|
4331AD
|
IMATINIB DENK 100MG TAB (EDK)
|
30'S
|
BQ
|
43.04
|
100MG
|
120
|
2026-04-01
|
|
No
|
No
|
|
0
|
|
|
40
|
4331AN
|
XELJANZ 5MG TAB (PFI/STO) TOFACITINIB
|
60'S
|
C
|
39.56
|
5MG
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
|
41
|
4331AN
|
XELJANZ 5MG TAB (PFI) TOFACITINIB (C)
|
60'S
|
C
|
39.5571
|
5MG
|
0
|
2024-04-01
|
2026-03-31
|
|
|
|
0
|
|
|
42
|
4331AN
|
XELJANZ 5MG TAB (PFI) TOFACITINIB
|
60'S
|
C
|
39.56
|
5MG
|
0
|
2026-04-01
|
|
No
|
No
|
|
0
|
|
|
41
|
4331BA
|
APO-IMATINIB 100MG TAB (APO) IMATIN (BQ)
|
30'S
|
BQ
|
1.1508
|
100MG
|
120
|
2024-04-01
|
2026-03-31
|
|
|
|
0
|
|
|
41
|
4331BB
|
ZIMITIB 100MG CAP (ZUV) IMATINIB (BQ)
|
120'S
|
BQ
|
0.5147
|
100MG
|
120
|
2024-04-01
|
2024-05-17
|
|
|
|
6
|
|
|
41
|
4331BD
|
ZIMITIB 100 CAP (ZUV) IMATINIB
|
30'S
|
BQ
|
1.5893
|
100
|
|
2024-04-05
|
2026-03-31
|
|
|
|
|
|
|
40
|
4331E
|
SUTENT 50MG TAB (PFI/STO) SUNITINIB
|
28'S
|
C
|
452.29
|
50MG
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
|
41
|
4331E
|
SUTENT 50MG TAB (PFI) SUNITINIB (BQ)
|
28'S
|
BQ
|
452.2913
|
50MG
|
0
|
2024-04-01
|
2026-03-31
|
|
|
|
6
|
|
|
42
|
4331E
|
SUTENT 50MG CAP (PFI) SUNITINIB
|
28'S
|
C
|
452.29
|
50MG
|
0
|
2026-04-01
|
|
No
|
No
|
|
6
|
|
|
40
|
4331G
|
TASIGNA 150MG CAP (NVS/COL) NILOTANIB
|
112'S
|
C
|
102.60
|
150MG
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
|
41
|
4331G
|
TASIGNA 150MG CAP (NVS) NILOTANIB (BQ)
|
112'S
|
BQ
|
67.9581
|
150MG
|
0
|
2024-04-01
|
2026-03-31
|
|
|
|
0
|
|
|
42
|
4331G
|
TASIGNA 150MG CAP (NVS) NILOTANIB
|
112'S
|
C
|
67.96
|
150MG
|
0
|
2026-04-01
|
|
No
|
No
|
|
0
|
|
|
40
|
4331L
|
AFINITOR 5MG TAB (NVS/COL) EVEROLIMUS
|
30'S
|
C
|
181.22
|
5MG
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
